* Nephros Inc NEPH.OQ reported a quarterly adjusted loss
of 2
cents per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of -3
cents. The mean expectation of two analysts for the quarter was
for a loss of 4 cents per share. Wall Street expected results to
range from -6 cents to -2 cents per share.
* Revenue fell 4.7% to $3.52 million from a year ago;
analysts
expected $3.73 million.
* Nephros Inc's reported EPS for the quarter was a loss of 2
cents.
* The company reported a quarterly loss of $169 thousand.
* Nephros Inc shares had fallen by 0.9% this quarter and
lost 37.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 33.3%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the environmental
services & equipment peer group is also "buy"
Wall Street's median 12-month price target for Nephros Inc is
$4.75
This summary was machine generated from LSEG data May 9 at 11:55
p.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.04 -0.02 Beat
Dec. 31 2023 -0.02 -0.06 Missed
Sep. 30 2023 -0.06 -0.02 Beat
Jun. 30 2023 -0.05 -0.04 Beat